PDGFRB and central nervous system cancer: Various gangliosides were shown to inhibit PDGF-dependent tyrosine phosphorylation of PDGFR in several cell types including Swiss 3T3 [76], human glioma cells [77], and neuroblastoma SH-SY5Y cells [78].